Copyright Reports & Markets. All rights reserved.

Global Sulfonamide API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sulfonamide API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Sulfanilamide
    • 1.3.3 Sulfachloropyridazine Sodium
    • 1.3.4 Sulfachloropyrazine Sodium
    • 1.3.5 Sulfamonomethoxine
    • 1.3.6 Sulfamonomethoxine Sodium
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sulfonamide API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Antimicrobial Drugs for Human Use
    • 1.4.3 Antimicrobial Drugs for Veterinary Use
  • 1.5 Global Sulfonamide API Market Size & Forecast
    • 1.5.1 Global Sulfonamide API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Sulfonamide API Sales Quantity (2020-2031)
    • 1.5.3 Global Sulfonamide API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Zhejiang Chemsyn Pharm
    • 2.1.1 Zhejiang Chemsyn Pharm Details
    • 2.1.2 Zhejiang Chemsyn Pharm Major Business
    • 2.1.3 Zhejiang Chemsyn Pharm Sulfonamide API Product and Services
    • 2.1.4 Zhejiang Chemsyn Pharm Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Zhejiang Chemsyn Pharm Recent Developments/Updates
  • 2.2 Wujiang Bolin Industry
    • 2.2.1 Wujiang Bolin Industry Details
    • 2.2.2 Wujiang Bolin Industry Major Business
    • 2.2.3 Wujiang Bolin Industry Sulfonamide API Product and Services
    • 2.2.4 Wujiang Bolin Industry Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Wujiang Bolin Industry Recent Developments/Updates
  • 2.3 Wugan Pharmaceutical
    • 2.3.1 Wugan Pharmaceutical Details
    • 2.3.2 Wugan Pharmaceutical Major Business
    • 2.3.3 Wugan Pharmaceutical Sulfonamide API Product and Services
    • 2.3.4 Wugan Pharmaceutical Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Wugan Pharmaceutical Recent Developments/Updates
  • 2.4 Nanhai Beisha Pharmaceutical
    • 2.4.1 Nanhai Beisha Pharmaceutical Details
    • 2.4.2 Nanhai Beisha Pharmaceutical Major Business
    • 2.4.3 Nanhai Beisha Pharmaceutical Sulfonamide API Product and Services
    • 2.4.4 Nanhai Beisha Pharmaceutical Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Nanhai Beisha Pharmaceutical Recent Developments/Updates
  • 2.5 Hefei TNJ Chemical
    • 2.5.1 Hefei TNJ Chemical Details
    • 2.5.2 Hefei TNJ Chemical Major Business
    • 2.5.3 Hefei TNJ Chemical Sulfonamide API Product and Services
    • 2.5.4 Hefei TNJ Chemical Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hefei TNJ Chemical Recent Developments/Updates
  • 2.6 Quimica Alkano
    • 2.6.1 Quimica Alkano Details
    • 2.6.2 Quimica Alkano Major Business
    • 2.6.3 Quimica Alkano Sulfonamide API Product and Services
    • 2.6.4 Quimica Alkano Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Quimica Alkano Recent Developments/Updates
  • 2.7 Ofichem
    • 2.7.1 Ofichem Details
    • 2.7.2 Ofichem Major Business
    • 2.7.3 Ofichem Sulfonamide API Product and Services
    • 2.7.4 Ofichem Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Ofichem Recent Developments/Updates
  • 2.8 TIANHE PHARMACEUTICAL
    • 2.8.1 TIANHE PHARMACEUTICAL Details
    • 2.8.2 TIANHE PHARMACEUTICAL Major Business
    • 2.8.3 TIANHE PHARMACEUTICAL Sulfonamide API Product and Services
    • 2.8.4 TIANHE PHARMACEUTICAL Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 TIANHE PHARMACEUTICAL Recent Developments/Updates
  • 2.9 Nanyang Tianhua Pharmaceutical
    • 2.9.1 Nanyang Tianhua Pharmaceutical Details
    • 2.9.2 Nanyang Tianhua Pharmaceutical Major Business
    • 2.9.3 Nanyang Tianhua Pharmaceutical Sulfonamide API Product and Services
    • 2.9.4 Nanyang Tianhua Pharmaceutical Sulfonamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Nanyang Tianhua Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Sulfonamide API by Manufacturer

  • 3.1 Global Sulfonamide API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Sulfonamide API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Sulfonamide API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Sulfonamide API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Sulfonamide API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Sulfonamide API Manufacturer Market Share in 2024
  • 3.5 Sulfonamide API Market: Overall Company Footprint Analysis
    • 3.5.1 Sulfonamide API Market: Region Footprint
    • 3.5.2 Sulfonamide API Market: Company Product Type Footprint
    • 3.5.3 Sulfonamide API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sulfonamide API Market Size by Region
    • 4.1.1 Global Sulfonamide API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Sulfonamide API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Sulfonamide API Average Price by Region (2020-2031)
  • 4.2 North America Sulfonamide API Consumption Value (2020-2031)
  • 4.3 Europe Sulfonamide API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Sulfonamide API Consumption Value (2020-2031)
  • 4.5 South America Sulfonamide API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Sulfonamide API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Sulfonamide API Sales Quantity by Type (2020-2031)
  • 5.2 Global Sulfonamide API Consumption Value by Type (2020-2031)
  • 5.3 Global Sulfonamide API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Sulfonamide API Sales Quantity by Application (2020-2031)
  • 6.2 Global Sulfonamide API Consumption Value by Application (2020-2031)
  • 6.3 Global Sulfonamide API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Sulfonamide API Sales Quantity by Type (2020-2031)
  • 7.2 North America Sulfonamide API Sales Quantity by Application (2020-2031)
  • 7.3 North America Sulfonamide API Market Size by Country
    • 7.3.1 North America Sulfonamide API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Sulfonamide API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Sulfonamide API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Sulfonamide API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Sulfonamide API Market Size by Country
    • 8.3.1 Europe Sulfonamide API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Sulfonamide API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sulfonamide API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Sulfonamide API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Sulfonamide API Market Size by Region
    • 9.3.1 Asia-Pacific Sulfonamide API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Sulfonamide API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Sulfonamide API Sales Quantity by Type (2020-2031)
  • 10.2 South America Sulfonamide API Sales Quantity by Application (2020-2031)
  • 10.3 South America Sulfonamide API Market Size by Country
    • 10.3.1 South America Sulfonamide API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Sulfonamide API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sulfonamide API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Sulfonamide API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Sulfonamide API Market Size by Country
    • 11.3.1 Middle East & Africa Sulfonamide API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Sulfonamide API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Sulfonamide API Market Drivers
  • 12.2 Sulfonamide API Market Restraints
  • 12.3 Sulfonamide API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sulfonamide API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sulfonamide API
  • 13.3 Sulfonamide API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sulfonamide API Typical Distributors
  • 14.3 Sulfonamide API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sulfonamide API market size was valued at US$ 1620 million in 2024 and is forecast to a readjusted size of USD 2079 million by 2031 with a CAGR of 4.2% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Sulfonamide APIs are synthetic antibacterial compounds based on the sulfanilamide structure, inhibiting bacterial dihydropteroate synthase (DHPS) to disrupt folate synthesis. Covering sulfadiazine (SD), sulfamethoxazole (SMZ), and sulfadimidine (SM2), they target Gram-positive/negative bacteria and protozoa (e.g., malaria). Manufacturing involves sulfonation, condensation, and purification to meet USP/EP purity (≥99%). Used in human/veterinary drugs (e.g., cotrimoxazole), they remain critical for urinary/respiratory infections despite allergy and resistance concerns.
    This report is a detailed and comprehensive analysis for global Sulfonamide API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sulfonamide API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Sulfonamide API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Sulfonamide API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Sulfonamide API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sulfonamide API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sulfonamide API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhejiang Chemsyn Pharm, Wujiang Bolin Industry, Wugan Pharmaceutical, Nanhai Beisha Pharmaceutical, Hefei TNJ Chemical, Quimica Alkano, Ofichem, TIANHE PHARMACEUTICAL, Nanyang Tianhua Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sulfonamide API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Sulfanilamide
    Sulfachloropyridazine Sodium
    Sulfachloropyrazine Sodium
    Sulfamonomethoxine
    Sulfamonomethoxine Sodium
    Others
    Market segment by Application
    Antimicrobial Drugs for Human Use
    Antimicrobial Drugs for Veterinary Use
    Major players covered
    Zhejiang Chemsyn Pharm
    Wujiang Bolin Industry
    Wugan Pharmaceutical
    Nanhai Beisha Pharmaceutical
    Hefei TNJ Chemical
    Quimica Alkano
    Ofichem
    TIANHE PHARMACEUTICAL
    Nanyang Tianhua Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Sulfonamide API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sulfonamide API, with price, sales quantity, revenue, and global market share of Sulfonamide API from 2020 to 2025.
    Chapter 3, the Sulfonamide API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sulfonamide API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sulfonamide API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sulfonamide API.
    Chapter 14 and 15, to describe Sulfonamide API sales channel, distributors, customers, research findings and conclusion.

    Buy now